← Back

Gastroenterology

Diseases of the digestive system, including inflammatory bowel disease, liver disease, gastrointestinal cancers, endoscopy, and functional gastrointestinal disorders

12 papers

Papers

GastroGPT: Development and controlled testing of a proof-of-concept customized clinical language model

In a simulated test, the specialized AI model GastroGPT performed better than general AI models in several key gastroenterology tasks, such as diagnosis, treatment planning, and patient counseling. However, the study was limited by its use of simulated cases, and further research with real patient data is necessary to confirm its real-world applicability.

Gastroenterology Aug 28, 04:25 PM

Efficacy and Safety of Vonoprazan and High-Dose Amoxicillin Dual Therapy for Rescue Treatment of Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

This study found that a 14-day dual therapy of vonoprazan and high-dose amoxicillin (VHA) was as effective as the standard bismuth-containing quadruple therapy (BQT) for treating persistent H. pylori infection after initial treatment failure. Importantly, the VHA therapy resulted in significantly fewer side effects. Further research is needed to confirm these results in diverse populations and evaluate the role of antibiotic resistance testing.

Gastroenterology Aug 20, 03:25 PM

Small and Stable Pancreatic Cysts Are Reassuring During Surveillance: Results From the PACYFIC Trial

In a large observational study of patients with pancreatic cysts, small (<15 mm) and slow-growing (<2.5 mm/year) cysts without other risk factors were associated with a very low risk of developing high-grade dysplasia or pancreatic cancer, similar to the risk in the general population. This suggests that less frequent surveillance may be adequate for these "low-risk" cysts. However, caution is warranted due to limitations related to non-standardized management, inconsistent imaging modality use, and potential referral bias.

Gastroenterology Aug 18, 08:05 PM

Sphingosine-1-Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety

Ozanimod and etrasimod, two new drugs for ulcerative colitis, work by stopping lymphocytes from reaching the inflamed colon, leading to reduced inflammation and improved symptoms. While clinical trials indicate a manageable safety profile, potential for cardiovascular, ocular, hepatic, pulmonary, and infectious complications necessitates precautions and careful monitoring.

Gastroenterology Aug 16, 04:25 PM

Quality Upper Gastrointestinal Endoscopy in Australia and Aotearoa New Zealand: A Joint Position Statement

This paper presents a joint position statement on quality standards for upper gastrointestinal (UGI) endoscopy in Australia and Aotearoa New Zealand, covering pre-, intra-, and post-procedural recommendations. It emphasizes the need for tailored guidelines relevant to the diverse patient population and healthcare settings of the region, and also gives recommendations for specific conditions of the esophagus, stomach, and duodenum.

Gastroenterology Aug 12, 04:37 PM

Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance

This review paper suggests a correlation between glyphosate exposure and celiac disease due to alterations in gut bacteria, impaired nutrient absorption, and inhibited enzyme function. However, it's crucial to note that this study relies on correlations, animal data, and proposed mechanisms without direct causal evidence in humans, making its conclusions speculative. Further, independent research is needed to confirm these claims.

Gastroenterology Aug 12, 01:48 PM

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

This guideline recommends adjusting proton pump inhibitor (PPI) dosing based on a patient's CYP2C19 genotype to optimize efficacy and minimize adverse effects. Patients with genotypes predicting lower PPI exposure (rapid metabolizers) may benefit from higher doses, while those with genotypes predicting higher exposure (intermediate and poor metabolizers) may benefit from lower doses, especially during long-term therapy.

Gastroenterology Jul 14, 11:13 AM

Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

The guideline recommends endoscopic ultrasound (EUS) as the primary tool for characterizing subepithelial lesions (SELs). It suggests tissue diagnosis for SELs with GIST features if they are >20mm or high-risk, recommends endoscopic resection for growing type 1 gastric NENs, and advises against surveillance for most benign SELs if the diagnosis is clear.

Gastroenterology Jul 14, 11:12 AM